MX2018014301A - Hppd variants and methods of use. - Google Patents

Hppd variants and methods of use.

Info

Publication number
MX2018014301A
MX2018014301A MX2018014301A MX2018014301A MX2018014301A MX 2018014301 A MX2018014301 A MX 2018014301A MX 2018014301 A MX2018014301 A MX 2018014301A MX 2018014301 A MX2018014301 A MX 2018014301A MX 2018014301 A MX2018014301 A MX 2018014301A
Authority
MX
Mexico
Prior art keywords
hppd
inhibitors
slow
binding
enzymes
Prior art date
Application number
MX2018014301A
Other languages
Spanish (es)
Inventor
Bernd Laber
Manuel Dubald
Roxanne Armstrong
Fabien Poree
Gudrun Lange
Original Assignee
Bayer Cropscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag filed Critical Bayer Cropscience Ag
Publication of MX2018014301A publication Critical patent/MX2018014301A/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

In the present invention, HPPD enzymes and plants containing them showing a full tolerance against several classes of HPPD-inhibitors are described. A set of HPPD enzymes have been designed which have either no or only a significantly reduced affinity to HPPD inhibitors and, at the same time, the rate of dissociation of the HPPD inhibitors of the enzyme is increased to such an extent that the HPPD inhibitors no longer act as slow-binding or slow, tight-binding inhibitors but, instead of this, have become fully reversible inhibitors. In particular, isolated polynucleotides encoding HPPD inhibitor tolerance polypeptides are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed.
MX2018014301A 2014-03-11 2016-09-09 Hppd variants and methods of use. MX2018014301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461951039P 2014-03-11 2014-03-11
EP14159634 2014-03-13

Publications (1)

Publication Number Publication Date
MX2018014301A true MX2018014301A (en) 2020-09-14

Family

ID=74214410

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018014301A MX2018014301A (en) 2014-03-11 2016-09-09 Hppd variants and methods of use.

Country Status (2)

Country Link
MX (1) MX2018014301A (en)
UA (1) UA118470C2 (en)

Also Published As

Publication number Publication date
UA118470C2 (en) 2019-01-25

Similar Documents

Publication Publication Date Title
MX360999B (en) Hppd variants and methods of use.
MX2016011745A (en) Hppd variants and methods of use.
PH12018501355A1 (en) Rsv f protein mutants
MX2018003044A (en) Hppd variants and methods of use.
JOP20220242A1 (en) Nucleic acids encoding antibodies specifically binding to masp-3
MX2021010482A (en) Compounds and methods for the enhanced degradation of targeted proteins.
MX2021012589A (en) Piperidine derivatives as inhibitors of ubiquitin specific protease 7.
MX2018008052A (en) Lsd1 inhibitors.
WO2016055777A3 (en) Modified enzymes
MX2020005213A (en) Mk2 inhibitors and uses thereof.
MX2022001085A (en) Humanized anti-c1s antibodies and methods of use thereof.
AU2017317563A8 (en) Detergent compositions comprising xanthan lyase variants I
EP3936141A3 (en) Anti-senescence compounds and uses thereof
SG10201806926YA (en) Method for masking bitterness of composition containing collagen peptide
MD20180042A2 (en) Methods for treating conditions associated with MASP-2-dependent complement activation
MX2019001011A (en) Pharmaceutical compounds.
MX2020001793A (en) Ahr inhibitors and uses thereof.
MA39824A (en) Amido-substituted azole compounds as inhibitors of tnks1 and/or tnks2
EP4234552A3 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
AU2015311730A8 (en) CaMKII inhibitors and uses thereof
IN2014DE00902A (en)
MY196740A (en) Engineered phenylalanine ammonia lyase polypeptides
PH12017502345A1 (en) Novel thrombin inhibitors
MX2018004187A (en) Methods and compositions for preventing or treating cancer.
MX2018014301A (en) Hppd variants and methods of use.